Technology | Mammography | January 24, 2017

FDA Approves Fujifilm's 3-D Mammography

U.S. customers now have access to optional tomosynthesis software upgrade for Aspire Cristalle full field digital mammography system

Fujifilm, Aspire Cristalle full field digital mammography system, digital breast tomosynthesis, DBT software upgrade, FDA approval

January 24, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced that its Digital Breast Tomosynthesis (DBT) software upgrade for its Aspire Cristalle digital mammography system, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The optional DBT upgrade is now available in the United States.

Radiologists using the Aspire Cristalle full field digital mammography (FFDM) system with DBT will realize enhanced clinical efficiency compared to using FFDM alone. This includes superior diagnostic accuracy and lower recall rates for non-cancer cases, according to Fujifilm.

Known as Amulet Innovality outside of the United States, the optional DBT upgrade has been widely available in Europe, Asia and Latin America since May 2013. The Aspire Cristalle FFDM system with DBT combines Fujifilm’s hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow to optimize patient dose while maximizing image quality.

With the DBT software option, the X-ray tube moves through an arc around the breast, acquiring a series of low-dose image slices at different angles, producing a three-dimensional view allowing radiologists to see through tissue less obstructed. The acquired images are reconstructed into a series of high-resolution 1 millimeter slices displayed individually or dynamically in a cine mode — making it easier to identify lesions that might be difficult to see in traditional 2-D mammography images due to overlapping breast structures. This will bring a new level of diagnostic confidence in screening, and especially for those women with dense breast tissue who are at higher than average risk and more difficult to screen with traditional 2-D only.

The Aspire Cristalle FFDM system with DBT will be on display at the National Consortium of Breast Centers (NCoBC) conference, March 11-13, 2017 in Las Vegas, and the Society of Breast Imaging (SBI) Symposium, April 6-9, 2017, in Los Angeles.

For more information: www.fujimed.com

Related Content

Medsquare, VirtualDose CT module, organ dose calculation, DACS Radiation Dose Monitor, RDM
Technology | Radiation Dose Management | March 24, 2017
Medsquare announced the integration of the organ dose module VirtualDose CT into its DACS (dose archive and...
GE Healthcare, Senographe Pristina mammography system, launch, RSNA 2017, patient comfort
News | Mammography | March 24, 2017
GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening...
ContextVision, 3-D ultrasound, SkeletalView, patent, fetal skeleton viewing, RSNA 2017
News | Advanced Visualization | March 23, 2017
ContextVision recently received a patent approval on a new skeletal visualization technology for 3-D ultrasound.
Sectra, enterprise imaging, RIS, PACS, VNA, Danderyd Hospital, Sweden, RSNA 2017
News | Enterprise Imaging | March 23, 2017
March 23, 2017 — Swedish healthcare provider Danderyd Hospital AB has signed a five-year contract with Sectra for the
Carestream, Touch Prime ultrasound systems, AIUM 2017 convention, American Institute of Ultrasound in Medicine, RSNA 2017
News | Ultrasound Imaging | March 22, 2017
Carestream Health will show its Carestream Touch Prime and Touch Prime XE Ultrasound Systems at the American Institute...
moblie lung CT unit, first in the U.S., Carolinas, Levine Cancer Institute, Samsung NeuroLogica, BodyTom CT scanner
News | Computed Tomography (CT) | March 22, 2017
Samsung NeuroLogica announced that its portable computed tomography (CT) technology will be included in Carolinas...
Toshiba, Aquilion One CT, model-based iterative reconstruction, MBIR, ACC 2017, FIRST, RSNA 2017
News | Computed Tomography (CT) | March 21, 2017
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FI
Agfa HealthCare, Enterprise Imaging for Cardiology, ACC.17, IBM Watson Health
Technology | Enterprise Imaging | March 20, 2017
Agfa HealthCare announced the release a new version of its Enterprise Imaging for Cardiology platform at the American...
Toshiba Medical, Aplio i900 cardiovascular ultrasound, FDA clearance, ACC 2017, RSNA 2017
Technology | Cardiovascular Ultrasound | March 20, 2017
March 20, 2017 — Cardiologists can now access the advanced...
Solis Mammography, minimize recall rates, false positives, breast cancer, women's health
News | Mammography | March 16, 2017
Solis Mammography recently released a statement taking issue with incorrectly interpreted terminology used by reporters...
Overlay Init